EUVIMEDEUVIMED entdecken
Open Access

Segmental defect healing in the presence or absence of recombinant human BMP2: Novel insights from a rat model

Joseph A Panos iD, Michael J Coenen, Christopher V Nagelli, Erin B McGlinch, Aysegul Atasoy-Zeybek, Consuelo Lopez De Padilla, Rodolfo E De la Vega, Christopher H Evans

Journal of Orthopaedic Research · 2023

DOI: 10.1002/jor.25530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2023. Verfasst von Joseph A Panos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Bone Regeneration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NICHD NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study defined and compared the course of native, impaired and growth factor‐stimulated bone regeneration in a rat femoral defect model. A mid‐diaphyseal defect with rigid internal fixation was surgically created in the right femur of male Fischer rats and serially analyzed over 36 weeks. Native bone regeneration was modeled using a sub‐critical, 1 mm size defect, which healed uneventfully. Critical size defects of 5 mm were used to analyze impaired bone regeneration. In a third group, the 5 mm defects were filled with 11 µg of recombinant human bone morphogenetic protein 2 (rhBMP2) impregnated onto an absorbable collagen sponge, modeling its clinical use. Native bone regeneration was characterized by endochondral ossification with progressive remodeling to ultimately resemble intact femora. An endochondral response was also observed under conditions of impaired bone regeneration, but by week 8 medullary capping occurred with fibrofatty consolidation of the tissue within the defect, resembling an atrophic non‐union. rhBMP2 treatment was associated with prolonged inflammatory cytokine expression and rapid intramembranous bone formation occurring with reduced expression of cartilage‐associated collagens. Between weeks 4 and 36, rhBMP2‐treated bones demonstrated decreased trabecular number and increased trabecular separation, which resulted in inferior mechanical properties compared with bones that healed naturally. Clinical Significance: Recombinant human bone morphogenetic protein 2 (rhBMP2) is used clinically to promote healing of long bones. Our data suggest that it drives intramembraneous ossification producing an inferior regenerate that deteriorates with time. Clinical outcomes would be improved by technologies favoring endochondral regenerative ossification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2Bone RegenerationRatsHumansMaleAnimalsWound HealingFemurOsteogenesisRecombinant Proteins

Stichwörter der Autor:innen

bone regenerationendochondral ossificationintramembranous ossificationnonunionrecombinant human bone morphogenetic protein 2

Substanzen

Bone Morphogenetic Protein 2Recombinant ProteinsBMP2 protein, human

Autor:innen und Institutionen

  • Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, Minnesota, USA.
  • Musculoskeletal Gene Therapy Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.
  • Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Medical Scientist Training Program, Mayo Clinic, Rochester, Minnesota, USA.
  • Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Cell Biology-Inspired Tissue Engineering, MERLN Institute, Maastricht, The Netherlands.

ORCID-Profile: Joseph A Panos

Förderung

  • NIAMS NIH HHS
  • NICHD NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Panos, J. A., Coenen, M. J., Nagelli, C. V., McGlinch, E. B., Atasoy-Zeybek, A., Lopez De Padilla, C., De la Vega, R. E., & Evans, C. H. (2023). Segmental defect healing in the presence or absence of recombinant human BMP2: Novel insights from a rat model. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25530

Vancouver

Panos JA, Coenen MJ, Nagelli CV, McGlinch EB, Atasoy-Zeybek A, Lopez De Padilla C, et al. Segmental defect healing in the presence or absence of recombinant human BMP2: Novel insights from a rat model. Journal of Orthopaedic Research. 2023. doi:10.1002/jor.25530

BibTeX
@article{Panos2023,
  author = {Panos, Joseph A and Coenen, Michael J and Nagelli, Christopher V and McGlinch, Erin B and Atasoy-Zeybek, Aysegul and Lopez De Padilla, Consuelo and De la Vega, Rodolfo E and Evans, Christopher H},
  title = {Segmental defect healing in the presence or absence of recombinant human BMP2: Novel insights from a rat model},
  journal = {Journal of Orthopaedic Research},
  year = {2023},
  doi = {10.1002/jor.25530}
}
Kostenlos starten →